Suchergebnisse - "Prantera, Cosimo"

PubPharm (66)

1

Challenges and Opportunities in IBD Clinical Trial Design

enthalten in: Gastroenterology | 2021

von Dubinsky, M. | Collins, R. | Abreu, M. | +94

2

SARS-CoV-2 vaccination for patients with inflammatory bowel diseases : recommendations from an international consensus meeting

enthalten in: Gut | 2021

von Siegel, C. | Melmed, G. | McGovern, D. | +68

3

Management of Patients With Crohn's Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic : Results of an International Meeting

enthalten in: Gastroenterology | 2020

von Rubin, D. | Abreu, M. | Rai, V. | +74

CommentIn: Gastroenterology. 2021 May;160(6):2196-2197. - PMID 32407806

4

Depression and Disease Course in Inflammatory Bowel Disease

enthalten in: The American journal of gastroenterology | 2018

von Levenstein, S. | Prantera, C.

CommentOn: Am J Gastroenterol. 2018 Jan;113(1):80-85. - PMID 29134965

5

Five-year Safety Data From ENCORE, a European Observational Safety Registry for Adults With Crohn's Disease Treated With Infliximab [Remicade®] or Conventional Therapy

enthalten in: Journal of Crohn's & colitis | 2017

von D'Haens, G. | Reinisch, W. | Colombel, J. | +10

6

Psychological Factors, Symptoms, and Mucosal Inflammation in Inflammatory Bowel Disease

enthalten in: The American journal of gastroenterology | 2016

von Levenstein, S. | Prantera, C.

CommentOn: Am J Gastroenterol. 2016 Apr;111(4):541-51. - PMID 27002800

7

Diet in Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2016

von Prantera, C. | Levenstein, S.

CommentOn: Clin Gastroenterol Hepatol. 2014 Oct;12(10):1592-600. - PMID 24107394

8

Diet in Crohn's Disease

enthalten in: Clinical gastroenterology and hepatology | 2016

von Prantera, C. | Levenstein, S.

9

A phase 2 study of tofacitinib, an oral Janus kinase inhibitor, in patients with Crohn's disease

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2014

von Sandborn, W. | Ghosh, S. | Panes, J. | +66

10

A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease

enthalten in: Clinical gastroenterology and hepatology | 2014

von Sandborn, W. | Ghosh, S. | Panes, J. | +65

1
2
3
4
5
6
7
Nächster »
[7]